In advance of CPhI, Cambrex and Wilmington PharmaTech both just announced big investments in US plants that make active ...
Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...
RBC Capital raised the firm’s price target on Adverum Biotechnologies (ADVM) to $4 from $3 and keeps a Sector Perform rating on the shares. The ...
Eli Lilly acquired Adverum, gaining access to Ixo-vec, a gene therapy for wet age-related macular degeneration. Read why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback